Literature for peptidase M14.009: carboxypeptidase B2

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(References are filtered for relevance to Review. To remove the filter click here. See explanation.)

    2016
  1. Plug,T. and Meijers,J.C.
    Structure-function relationships in thrombin-activatable fibrinolysis inhibitor
    J Thromb Haemost14, 633-644. PubMed  Europe PubMed DOI  V
  2. 2013
  3. Fernandez,D., Pallares,I., Covaleda,G., Aviles,F.X. and Vendrell,J.
    Metallocarboxypeptidases and their Inhibitors: Recent Developments in Biomedically Relevant Protein and Organic Ligands
    Curr Med Chem20, 1595-1608. PubMed  Europe PubMed  V  S  I
  4. 2011
  5. Declerck,P.J.
    Thrombin activatable fibrinolysis inhibitor
    Hamostaseologie31, 165-173. PubMed  Europe PubMed DOI  V
  6. Heylen,E., Willemse,J. and Hendriks,D.
    An update on the role of carboxypeptidase U (TAFIa) in fibrinolysis
    Front Biosci16, 2427-2450. PubMed  Europe PubMed DOI  V
  7. 2009
  8. Marx,P.F., Verkleij,C.J., Seron,M.V. and Meijers,J.C.
    Recent developments in thrombin-activatable fibrinolysis inhibitor research
    Mini Rev Med Chem9, 1165-1173. PubMed  Europe PubMed DOI  V
  9. Willemse,J.L., Heylen,E., Nesheim,M.E. and Hendriks,D.F.
    Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?
    J Thromb Haemost7, 1962-1971. PubMed  Europe PubMed DOI  V
  10. 2007
  11. Boffa,M.B. and Koschinsky,M.L.
    Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles
    Clin Biochem40, 431-442. PubMed  Europe PubMed DOI  V
  12. 2006
  13. Bouma,B.N. and Mosnier,L.O.
    Thrombin activatable fibrinolysis inhibitor (TAFI) - how does thrombin regulate fibrinolysis?
    Ann Med38, 378-388. PubMed  Europe PubMed DOI  V
  14. [YEAR:7-9-2006]Mosnier,L.O. and Bouma,B.N.
    Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis
    Arterioscler Thromb Vasc Biol26, 2445-2453. PubMed  Europe PubMed DOI  V
  15. 2004
  16. Hendriks,D.F.
    Carboxypeptidase U
    [ISSN:0-12-079610-4]2, 825-828.  V
  17. Marx,P.F.
    Thrombin-activatable fibrinolysis inhibitor
    Curr Med Chem11, 2335-2348. PubMed  Europe PubMed  V
  18. 2003
  19. [YEAR:20-9-2003]Bouma,B.N. and Mosnier,L.O.
    Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis
    Pathophysiol Haemost Thromb33, 375-381. PubMed  Europe PubMed DOI  V
  20. 2000
  21. Bajzar,L.
    Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway
    Arterioscler Thromb Vasc Biol20, 2511-2518. PubMed  Europe PubMed  V
  22. 1998
  23. Nesheim,M.
    Fibrinolysis and the plasma carboxypeptidase
    Curr Opin Hematol5, 309-313. PubMed  Europe PubMed  V